Schizophrenia trials in Puerto Rico

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  Where

  San Juan

  Age

  5 years to 17 years

  People

  400 worldwide

  Run by

  Karuna Therapeutics, Inc., a Bristol Myers Squibb company

  See details and how to joinNCT07424404 · EU 2025-524062-16-00
• Phase 3Taking people
  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  Where

  Bayamón, San Juan

  Age

  55 years to 90 years

  People

  406 worldwide

  Run by

  Karuna Therapeutics, Inc., a Bristol Myers Squibb company

  See details and how to joinNCT06585787 · EU 2024-516363-92-00
• Phase 3Taking people
  NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  Where

  San Juan

  Age

  18 years to 65 years

  People

  600 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT07114874 · EU 2025-521216-19-00
• Phase 3Taking people
  Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

  Where

  San Juan

  Age

  18 years to 65 years

  People

  560 worldwide

  Run by

  Neurocrine Biosciences

  See details and how to joinNCT07227818